SNYR
Synergy CHC Corp. Common Stock
MEDICINAL CHEMICALS & BOTANICAL PRODUCTS
Synergy CHC (SNYR) Stock: Buy, Sell, or Hold?
$0.09
-0.18 (-67.02%)
▼
5d:
-16.2%
30d:
-16.28%
90d:
-56.64%
Open in Live Scanner
70/30 Portfolio Builder
Last Earnings: Sep 17, 2026
Updated Sep 17, 12:00 AM ET
QUANTITATIVE VERDICT
WAIT
LOW Confidence (41%)
Quality Score
33/100
Position
FAIR
Forward P/E & Valuation
0.6x
CHEAP
vs 2.9x historical avg
Wall Street Target
$3.75
+4043.6% upside
Options IV & Volume
UNKNOWN Vol
UNKNOWN volume confirmation
Support / Resistance
$0.07 / $0.64
Trend: Strong Downtrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
⏸️ WAIT FOR STABILIZATION: SNYR is down 16.2% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
Get Alerted When SNYR Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: SNYR is currently trading at $0.09, which is considered fair based on recent price action. From a valuation perspective, the stock is trading at a discount (Forward PE: 0.6) compared to its historical average (2.9). Remarkably, the market is currently pricing in an annual earnings decline of 40.8% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, SNYR is in a strong downtrend. Immediate support is located at $0.07, while resistance sits at $0.64. Short-term momentum is weak, with the stock down 67.0% recently.
Market Sentiment: SNYR scores 5/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $3.75 (+4043.6%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, SNYR is in a strong downtrend. Immediate support is located at $0.07, while resistance sits at $0.64. Short-term momentum is weak, with the stock down 67.0% recently.
Market Sentiment: SNYR scores 5/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $3.75 (+4043.6%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Company Quality Score
33/100
(SELL)
Volume Confirmation
UNKNOWN
Confidence Score
40.5%
Trading Range & Key Levels
Support Level
$0.07
Resistance Level
$0.64
Current Trend
Strong Downtrend
Technical data as of
Sep 17, 2026
Quantitative Signal Breakdown
- NEUTRAL: Price in fair range
- BEARISH: Weak technical setup (5/100)
- BEARISH: Downward momentum (-67.0%)
- BULLISH: Trading 4043.6% below Wall St target ($3.75)
- WARNING: Composite score 33/100 in the bottom quintile — this cohort historically lags the market
Fundamental Context
Forward P/E (Next Year Est.)
0.60
Wall Street Target
$3.75
(+4043.6%)
Revenue Growth (YoY)
-32.8%
Earnings Growth (YoY)
-90.6%
Profit Margin
-57.0%
Valuation Discount vs History
-40.8% cheaper
PE vs Historical
0.6 vs 2.9
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-40.8%
(market-implied from PE analysis)
1-Year Target
$0.08
(-10%)
2-Year Target
$0.07
(-19%)
3-Year Target
$0.07
(-27%)
3-Yr Target (if PE normalizes)
(PE: 1→3)
$0.32
(+250%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 0.6 to 2.9
Stabilization Target:
$0.44
(+380.7%)
PE Expansion Potential:
+380.7%
Share SNYR Analysis
Share this live SNYR analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (SNYR)
Bullish
2 Retail Mentions
Retail Stream Volume
2 msgs
24h retail stream
Last Tracked
Aug 18, 2026
Daily AI digest
AI Retail Discussion Summary:
StockTwits messages indicate strong bullish sentiment towards $SNYR, with traders expressing confidence in the stock's continued rise. No recent Yahoo Finance news articles were available.
Key Retail Themes:
Bullish sentiment
Trader confidence
Aggregated from r/wallstreetbets, r/stocks & retail trader streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 22, 2026 7:51 AM ET
Data refreshes hourly during market hours. Next update: 8:51 AM
Data refreshes hourly during market hours. Next update: 8:51 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is SNYR showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Distribution Stocks
Top-rated stocks in Medical Distribution by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
CAH
Cardinal Health Inc |
STRONG BUY
17 analysts |
$295 | 43 HOLD |
|
MCK
McKesson Corporation |
STRONG BUY
16 analysts |
$1144 | 43 HOLD |
|
COR
Cencora Inc. |
STRONG BUY
14 analysts |
$382 | 47 HOLD |
|
HSIC
Henry Schein Inc |
BUY
16 analysts |
$97 | 54 HOLD |
|
QIPT
Quipt Home Medical Corp |
STRONG BUY
5 analysts |
$4 | 52 HOLD |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive SNYR Research Pages
SNYR Technical Chart
SNYR Price Prediction
SNYR Intrinsic Value DCF
SNYR Earnings Date
SNYR Investment Advisor
SNYR Fair Price Analyzer
SNYR Target Price Playground
SNYR 5-Day Options Simulator
SNYR LEAP Simulator
SNYR Supply Chain Tear-Down
Engineering R&D & Supply-Chain Velocity Hub
AI Chip Cost & Reticle Wall Visualizer
House Thesis Scoreboard & Risk Guard
SNYR Competitors
Part B: Tradestie Flagship Market Scanners